Q4 2024 Earnings Forecast for CVS Health Co. (NYSE:CVS) Issued By Leerink Partnrs

CVS Health Co. (NYSE:CVS) – Equities research analysts at Leerink Partnrs reduced their Q4 2024 earnings per share (EPS) estimates for shares of CVS Health in a report issued on Wednesday, August 7th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will earn $1.65 per share for the quarter, down from their prior forecast of $1.93. Leerink Partnrs has a “Market Perform” rating on the stock. The consensus estimate for CVS Health’s current full-year earnings is $7.00 per share. Leerink Partnrs also issued estimates for CVS Health’s FY2026 earnings at $7.78 EPS and FY2027 earnings at $8.65 EPS.

CVS has been the subject of several other reports. Argus lowered their price objective on CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. Barclays dropped their price objective on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 8th. SVB Leerink restated a “market perform” rating and issued a $60.00 target price (down from $87.00) on shares of CVS Health in a research note on Wednesday, May 1st. The Goldman Sachs Group dropped their price target on CVS Health from $85.00 to $74.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Finally, UBS Group lowered shares of CVS Health from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $85.00 to $60.00 in a research report on Thursday, May 2nd. Twelve equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $73.24.

CVS Health Trading Up 0.0 %

NYSE CVS opened at $55.82 on Monday. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. CVS Health has a 12 month low of $52.77 and a 12 month high of $83.25. The company’s fifty day moving average price is $59.28 and its two-hundred day moving average price is $65.90. The company has a market capitalization of $70.07 billion, a price-to-earnings ratio of 9.81, a price-to-earnings-growth ratio of 0.57 and a beta of 0.52.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same period in the prior year, the company posted $2.21 EPS. CVS Health’s quarterly revenue was up 2.6% on a year-over-year basis.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were paid a $0.665 dividend. The ex-dividend date was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.77%. CVS Health’s dividend payout ratio is currently 46.75%.

Institutional Trading of CVS Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in shares of CVS Health during the fourth quarter worth $1,092,040,000. Capital International Investors boosted its stake in CVS Health by 47.4% in the 4th quarter. Capital International Investors now owns 33,691,698 shares of the pharmacy operator’s stock worth $2,660,298,000 after purchasing an additional 10,837,801 shares during the period. Pzena Investment Management LLC grew its position in CVS Health by 132.9% during the 2nd quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock worth $764,023,000 after purchasing an additional 7,382,931 shares in the last quarter. Capital World Investors lifted its holdings in shares of CVS Health by 8.0% in the first quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock valued at $3,491,643,000 after purchasing an additional 3,232,172 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its stake in CVS Health by 306.6% in the 4th quarter. Clearbridge Investments LLC now owns 3,046,216 shares of the pharmacy operator’s stock worth $240,529,000 after acquiring an additional 2,297,100 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.